Name | tert-butyl 4-(4-hydroxyphenyl)piperidine-1-carboxylate |
---|---|
Synonyms |
4-(1-tert.butyloxycarbonyl-4-piperidinyl)phenol
4-(4-hydroxy-phenyl)-piperidine-1-carboxylic acid tert-butyl ester 1-boc-4-(4-hydroxyphenyl)piperidine 1-Boc-4-p-hydroxyphenylpiperidine 1-Boc-4-Hydroxyphenylpiperidine |
Density | 1.121g/cm3 |
---|---|
Boiling Point | 407.3ºC at 760mmHg |
Molecular Formula | C16H23NO3 |
Molecular Weight | 277.35900 |
Flash Point | 200.1ºC |
Exact Mass | 277.16800 |
PSA | 49.77000 |
LogP | 3.44460 |
Vapour Pressure | 3.24E-07mmHg at 25°C |
Index of Refraction | 1.541 |
HS Code | 2933399090 |
---|
~% 149377-19-5 |
Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2004/69256 A1, 2004 ; Location in patent: Page/Page column 32 ; WO 2004/069256 A1 |
Precursor 2 | |
---|---|
DownStream 0 |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |